Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians

14Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The efflux pump, p-glycoprotein, controls bioavailability and excretion of pharmaceutical compounds. In the blood-brain barrier, p-glycoprotein regulates the delivery of pharmaceutical substances to the brain, influencing efficacy and side effects for some drugs notably antipsychotics. Common side effects to antipsychotics include obesity and metabolic disease. Polymorphisms in the ABCB1 gene coding for p-glycoprotein are associated with more severe side effects to neuro-pharmaceuticals as well as weight gain, indicating a potential link between p-glycoprotein function and metabolic regulation. Using microarray data analysis from 145 neurologically sound adults, this study investigated the association between body mass index (BMI) and ABCB1 expression in the frontal cortex. Increasing BMI values were associated with a statistically significantly reduced expression of ABCB1. Investigation of DNA methylation patterns in a subgroup of 52 individuals found that the methylation/expression ratios of ABCB1 were unaffected by increasing BMI values. Interestingly, the effect of BMI on ABCB1 expression appeared stronger in African Americans than in Caucasians.

References Powered by Scopus

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults

6490Citations
N/AReaders
Get full text

National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

3393Citations
N/AReaders
Get full text

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

2431Citations
N/AReaders
Get full text

Cited by Powered by Scopus

P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers

129Citations
N/AReaders
Get full text

P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease

89Citations
N/AReaders
Get full text

Chemoprotective and chemosensitizing effects of apigenin on cancer therapy

42Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vendelbo, J., Olesen, R. H., Lauridsen, J. K., Rungby, J., Kleinman, J. E., Hyde, T. M., & Larsen, A. (2018). Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians. Pharmacogenomics Journal, 18(1), 121–126. https://doi.org/10.1038/tpj.2016.74

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

50%

Researcher 11

39%

Lecturer / Post doc 2

7%

Professor / Associate Prof. 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

36%

Neuroscience 7

28%

Biochemistry, Genetics and Molecular Bi... 6

24%

Pharmacology, Toxicology and Pharmaceut... 3

12%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free